SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Alkem Laboratories

BSE: 539523 19 Aug 2025
Healthcare
₹ 5393.5
Alkem Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

Alkem Laboratories - Share Price & Details

Market Cap
₹64,436
High /Low
6,440 / 4,492
Stock P/E
28.3
Book Value
₹1,002
Dividend Yield
0.83
ROCE
20.4
ROE
₹19.4
Face Value
2.0
PEG Ratio
3.05
EVEBITDA
₹20.4
Debt
1,381
CMP / FCF
43.1
Debt to equity
₹0.12
NP Ann
2,215
High price all time
6,440
Piotroski score
₹7.0
Graham Number
2,076
No. Eq. Shares
12.0
Net CF
₹-186
Net profit
2,333
Price to book value
5.38
Interest Coverage
₹22.8
Low price all time
1,152
Industry PE
33.5
Reserves
₹11,961
Free Cash Flow
₹1,278

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
Alkem Laboratories Limited24887.56561.623721.752.0464,43628.3
AUROBINDO PHARMA LTD.29319.45591.328481.79.636398419.0
GLENMARK PHARMACEUTICALS LTD.24642.633302.2623949.2811.75489741.2

Peer Comparison Chart


About Alkem Laboratories

Alkem Laboratories Limited, with Security Code 539523, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Alkem Laboratories Ltd (BOM:539523) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus

(13 Aug 2025)
Alkem Laboratories Ltd (BOM:539523) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Read more →

Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth

(12 Aug 2025)
Alkem Labs Q1FY26 profit rose 22% YoY to ₹664.3 crore, with strong growth in India and international sales; company to boost focus on...
Read more →

Alkem Labs Q1 Results: Shares jump 7% after every parameter rises from last year

(12 Aug 2025)
Alkem Labs Q1 Results: Sales from India business rose 12% year-on-year to ₹2265 crore, while the US business sales grew 8.8% YoY to ₹698...
Read more →

Alkem Labs Q1 Profit Jumps 22% to Rs 664 Cr

(12 Aug 2025)
Alkem Laboratories reports a 22% increase in Q1 net profit, reaching Rs 664 crore. Revenue up 11% driven by domestic & international growth.
Read more →

Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%

(12 Aug 2025)
The shares of Alkem Laboratories and PN Gadgil Jewellers recorded significant rally on August 12 after the two companies reported strong...
Read more →

Alkem Laboratories And PN Gadgil Jewellers Share Price Surge On Strong Q1 FY26 Results

(12 Aug 2025)
Alkem Laboratories share price jumped 7.5% and PN Gadgil Jewellers rallied 10% after posting strong Q1 FY26 results.
Read more →

Company Updates